157 related articles for article (PubMed ID: 955496)
1. Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
Allan RN; Thistle JL; Hofmann AF
Gut; 1976 Jun; 17(6):413-9. PubMed ID: 955496
[TBL] [Abstract][Full Text] [Related]
2. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
[TBL] [Abstract][Full Text] [Related]
3. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
Cowen AE; Korman MG; Hofmann AF; Cass OW
Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
Cowen AE; Korman MG; Hofmann AF; Cass OW; Coffin SB
Gastroenterology; 1975 Jul; 69(1):67-76. PubMed ID: 1097294
[TBL] [Abstract][Full Text] [Related]
6. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Lithocholate kinetics in patients ingesting chenodeoxycholic (chenic) acid for gall stone dissolution.
Allan R; Hofmann AF
Gut; 1976 May; 17(5):394. PubMed ID: 1278751
[No Abstract] [Full Text] [Related]
8. Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.
Cowen AE; Korman MG; Hofmann AF; Thomas PJ
Gastroenterology; 1975 Jul; 69(1):77-82. PubMed ID: 1150037
[TBL] [Abstract][Full Text] [Related]
9. Bile acid conjugation in the chimpanzee: effective sulfation of lithocholic acid.
Schwenk M; Hofmann AF; Carlson GL; Carter JA; Coulston F; Greim H
Arch Toxicol; 1978 Apr; 40(2):109-18. PubMed ID: 580732
[TBL] [Abstract][Full Text] [Related]
10. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
Stiehl A; Raedsch R; Kommerell B
Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
[TBL] [Abstract][Full Text] [Related]
11. Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity.
Gadacz TR; Allan RN; Mack E; Hofmann AF
Gastroenterology; 1976 Jun; 70(6):1125-9. PubMed ID: 817960
[TBL] [Abstract][Full Text] [Related]
12. Lithocholate metabolism in baboons fed chenodeoxycholate.
Palmer RH; McSherry CK
J Lab Clin Med; 1982 Apr; 99(4):533-8. PubMed ID: 7061926
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
Arnfred T; Pedersen L
Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
[TBL] [Abstract][Full Text] [Related]
15. Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids.
Fromm H; Carlson GL; Hofmann AF; Farivar S; Amin P
Am J Physiol; 1980 Sep; 239(3):G161-6. PubMed ID: 7435569
[TBL] [Abstract][Full Text] [Related]
16. Taurine and glycine conjugation and sulfation of lithocholate in primary hepatocyte cultures.
Galle PR; Theilmann L; Raedsch R; Rudolph G; Kommerell B; Stiehl A
Biochim Biophys Acta; 1989 Jun; 1003(3):250-3. PubMed ID: 2742861
[TBL] [Abstract][Full Text] [Related]
17. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
18. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
19. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
20. [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)].
Fromm H; Erbler HC; Eschler A; Schmidt FW
Klin Wochenschr; 1976 Dec; 54(23):1125-31. PubMed ID: 1003870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
